Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbott Labs | NYSE | Healthcare | Healthcare Equipment & Supplies | US$218.06B | 16.3x | 0.13 | US$125.25 | -4.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 2.6% Upside | Upgrade to Pro+ | |
Thermo Fisher Scientific | NYSE | Healthcare | Healthcare Equipment & Supplies | US$167.87B | 26.8x | 4.26 | US$443.67 | -5.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 41.5% Upside | Upgrade to Pro+ | |
Intuitive Surgical | NASDAQ | Healthcare | Healthcare Equipment & Supplies | US$165.20B | 69.8x | 2.75 | US$459.41 | -7.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 27.7% Upside | Upgrade to Pro+ | |
Boston Scientific | NYSE | Healthcare | Healthcare Equipment & Supplies | US$135.39B | 72.5x | 4.71 | US$91.05 | -7.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19.3% Upside | Upgrade to Pro+ | |
Stryker | NYSE | Healthcare | Healthcare Equipment & Supplies | US$133.87B | 44.5x | -7.83 | US$349.25 | -5.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.2% Upside | Upgrade to Pro+ | |
Danaher | NYSE | Healthcare | Healthcare Equipment & Supplies | US$132.94B | 34.8x | -2.21 | US$185.45 | -6.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 33.9% Upside | Upgrade to Pro+ | |
Essilor International SA | OTC Markets | Healthcare | Healthcare Equipment & Supplies | US$122.39B | 47.3x | 52.44 | US$132.86 | -2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -10.9% Downside | Upgrade to Pro+ | |
Medtronic | NYSE | Healthcare | Healthcare Equipment & Supplies | US$107.25B | 25.5x | 6.91 | US$83.55 | -4.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.1% Upside | Upgrade to Pro+ | |
Becton Dickinson | NYSE | Healthcare | Healthcare Equipment & Supplies | US$59.85B | 35x | 0.92 | US$207.53 | -6.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24.1% Upside | Upgrade to Pro+ | |
Siemens Healthineers ADR | OTC Markets | Healthcare | Healthcare Equipment & Supplies | US$54.84B | 26.4x | 0.93 | US$24.11 | -5.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 33.5% Upside | Upgrade to Pro+ | |
Cencora Inc | NYSE | Healthcare | Healthcare Equipment & Supplies | US$54.32B | 39.5x | -1.63 | US$278.88 | -3.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -3.2% Downside | Upgrade to Pro+ | |
Alcon | NYSE | Healthcare | Healthcare Equipment & Supplies | US$41.76B | 40.7x | 10.13 | US$84.09 | -6.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.5% Upside | Upgrade to Pro+ | |
Edwards Lifesciences | NYSE | Healthcare | Healthcare Equipment & Supplies | US$41.14B | 30x | 0.15 | US$69.62 | -4.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 9.6% Upside | Upgrade to Pro+ | |
Hoya Corp | OTC Markets | Healthcare | Healthcare Equipment & Supplies | US$36.66B | 26.4x | 1.12 | US$100.79 | -4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 42.3% Upside | Upgrade to Pro+ | |
Veeva Systems A | NYSE | Healthcare | Healthcare Equipment & Supplies | US$34.98B | 48.1x | 1.56 | US$214.35 | -3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24% Upside | Upgrade to Pro+ | |
GE HealthCare | NASDAQ | Healthcare | Healthcare Equipment & Supplies | US$32.93B | 19.7x | 0.43 | US$62.61 | -13% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 41% Upside | Upgrade to Pro+ | |
IDEXX Labs | NASDAQ | Healthcare | Healthcare Equipment & Supplies | US$32.26B | 37.1x | 6.26 | US$397.59 | -3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26% Upside | Upgrade to Pro+ | |
Resmed ADR | OTC Markets | Healthcare | Healthcare Equipment & Supplies | US$30.54B | 24.3x | 0.64 | US$30 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ResMed | NYSE | Healthcare | Healthcare Equipment & Supplies | US$30.44B | 24.3x | 0.64 | US$207.02 | -3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 31.2% Upside | Upgrade to Pro+ | |
Agilent Technologies | NYSE | Healthcare | Healthcare Equipment & Supplies | US$29.98B | 23.9x | 6.13 | US$105.01 | -4.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 39.5% Upside | Upgrade to Pro+ | |
Terumo ADR | OTC Markets | Healthcare | Healthcare Equipment & Supplies | US$27.81B | 33x | 1.24 | US$18.20 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
DexCom | NASDAQ | Healthcare | Healthcare Equipment & Supplies | US$23.38B | 40.7x | 4.91 | US$59.73 | -3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Coloplast A | OTC Markets | Healthcare | Healthcare Equipment & Supplies | US$22.92B | 32.2x | -12.97 | US$10.03 | -2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 33.6% Upside | Upgrade to Pro+ | |
Zimmer Biomet | NYSE | Healthcare | Healthcare Equipment & Supplies | US$21.72B | 24.3x | -2.68 | US$109.13 | -3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5.6% Upside | Upgrade to Pro+ | |
Koninklijke Philips ADR | NYSE | Healthcare | Healthcare Equipment & Supplies | US$21.05B | -23.1x | 0.49 | US$22.39 | -6.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 38.3% Upside | Upgrade to Pro+ | |
STERIS | NYSE | Healthcare | Healthcare Equipment & Supplies | US$20.98B | 33.8x | -2.11 | US$212.84 | -3.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.8% Upside | Upgrade to Pro+ | |
Waters | NYSE | Healthcare | Healthcare Equipment & Supplies | US$19.55B | 30.1x | -28.13 | US$329.09 | -4.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.9% Upside | Upgrade to Pro+ | |
Straumann ADR | OTC Markets | Healthcare | Healthcare Equipment & Supplies | US$17.47B | 32.3x | 0.66 | US$10.65 | -6.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 48.9% Upside | Upgrade to Pro+ | |
Insulet | NASDAQ | Healthcare | Healthcare Equipment & Supplies | US$17.28B | 40.4x | 0.45 | US$245.37 | -4.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 25.4% Upside | Upgrade to Pro+ | |
Sonova Holding AG | OTC Markets | Healthcare | Healthcare Equipment & Supplies | US$16.48B | 24.6x | -4.71 | US$54.47 | -2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 33.7% Upside | Upgrade to Pro+ | |
Baxter | NYSE | Healthcare | Healthcare Equipment & Supplies | US$15B | -44.2x | 0.41 | US$29.23 | -6.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21.2% Upside | Upgrade to Pro+ | |
West Pharmaceutical Services | NYSE | Healthcare | Healthcare Equipment & Supplies | US$14.97B | 30.5x | -2.16 | US$206.33 | -6.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 29.6% Upside | Upgrade to Pro+ | |
Cooper | NASDAQ | Healthcare | Healthcare Equipment & Supplies | US$14.90B | 35.5x | 0.97 | US$74.43 | -4.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 40.7% Upside | Upgrade to Pro+ | |
Olympus Corp | OTC Markets | Healthcare | Healthcare Equipment & Supplies | US$14.16B | 22.2x | -0.35 | US$12.17 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hologic | NASDAQ | Healthcare | Healthcare Equipment & Supplies | US$13.84B | 19.4x | 0.36 | US$61.75 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 25.6% Upside | Upgrade to Pro+ | |
Solventum | NYSE | Healthcare | Healthcare Equipment & Supplies | US$12.14B | 29x | -0.42 | US$66.84 | -4.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.8% Upside | Upgrade to Pro+ | |
Illumina | NASDAQ | Healthcare | Healthcare Equipment & Supplies | US$11.81B | -13.2x | 0.34 | US$74.25 | -2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21.4% Upside | Upgrade to Pro+ | |
Sysmex Corp | OTC Markets | Healthcare | Healthcare Equipment & Supplies | US$11.65B | 29.5x | 1.06 | US$17.97 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Revvity | NYSE | Healthcare | Healthcare Equipment & Supplies | US$11.64B | 41.2x | -0.74 | US$96.82 | -3.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 39.5% Upside | Upgrade to Pro+ | |
Smith&Nephew SNATS | NYSE | Healthcare | Healthcare Equipment & Supplies | US$11.59B | 28.4x | 0.52 | US$26.48 | -5.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.1% Upside | Upgrade to Pro+ | |
Fisher Paykel Healthcare | OTC Markets | Healthcare | Healthcare Equipment & Supplies | US$11.29B | 111.5x | -3.37 | US$16.93 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Align | NASDAQ | Healthcare | Healthcare Equipment & Supplies | US$11.28B | 27x | -8.5 | US$152.90 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Avantor | NYSE | Healthcare | Healthcare Equipment & Supplies | US$10.41B | 14.4x | 0.13 | US$15.25 | -2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CochLear ADR | OTC Markets | Healthcare | Healthcare Equipment & Supplies | US$10.25B | 47.5x | 7.79 | US$77.83 | -8.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Penumbra Inc | NYSE | Healthcare | Healthcare Equipment & Supplies | US$10.14B | 726.6x | -8.71 | US$261.97 | -4.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14.6% Upside | Upgrade to Pro+ | |
Globus Medical | NYSE | Healthcare | Healthcare Equipment & Supplies | US$9.52B | 90.2x | -3.24 | US$69.21 | -3.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 38.9% Upside | Upgrade to Pro+ | |
Henry Schein | NASDAQ | Healthcare | Healthcare Equipment & Supplies | US$8.21B | 21.3x | -6.28 | US$66.03 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.1% Upside | Upgrade to Pro+ | |
Masimo | NASDAQ | Healthcare | Healthcare Equipment & Supplies | US$7.81B | -25.1x | 0.06 | US$144.37 | -5.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 32.6% Upside | Upgrade to Pro+ | |
Bio-Rad Labs B | NYSE | Healthcare | Healthcare Equipment & Supplies | US$7.65B | -3.5x | 0.02 | US$241.99 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bio-Rad Labs | NYSE | Healthcare | Healthcare Equipment & Supplies | US$7.18B | -3.7x | 0.02 | US$226.76 | -3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |